SCHEMBL30797693

SCHEMBL30797693

C[C@@H](CO[Si](C)(C)C(C)(C)C)Oc1cc(CO)cc(OC(F)(F)F)c1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.31
VNN1 O95497 1/20 0.30
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27378268 1.00 FFAR4 (0.31) FFAR4VNN1MGLL
SCHEMBL27377080 1.00 FFAR4 (0.31) FFAR4VNN1MGLL
SCHEMBL30797822 0.82 MRGPRX4 (0.37)
SCHEMBL27377075 0.82 MRGPRX4 (0.37)
SCHEMBL27378263 0.82 MRGPRX4 (0.37)
SCHEMBL30797651 0.82 MRGPRX4 (0.37)
SCHEMBL27378280 0.80 FFAR4 (0.36) FFAR4VNN1MGLL
SCHEMBL27377085 0.80 FFAR4 (0.36) FFAR4VNN1MGLL
SCHEMBL25273322 0.79 CYP11B1 (0.33)
SCHEMBL31052353 0.79 CYP11B1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584266-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF Cambridge Enterprise Limited (GB) 2025-07-16 EP disclosed
WO-2024052701-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 WO disclosed